Subscribe
shutterstock_1712506348_martinsarts
MartinsArts / Shutterstock.com
8 December 2022AmericasStaff Writer

US supports delay to COVID waiver extension

Extension is “pathetic” says vaccine charity coalition | US Trade Representative says extra time will “help the world make a more informed decision” about controversial patent waiver.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.


Editor's picks

AstraZeneca unit faces class-action suit over alleged Soliris monopoly
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

Editor's picks

Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025

More on this story

Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.

More on this story

Americas
WTO waiver decision postponed
20 December 2022   Members agreed to a partial waiver of patent protection for COVID-19 vaccines | Latest delay follows a similar decision by the US | WTO accused of “failure”.
article
WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?
23 June 2022   The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight.

More features

Fenwick establishes new Boston office with trio of IP partners from Cooley
How pharma should prep for the six-bill avalanche from Congress
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
USPTO speeds up patent issuance amid widespread agency changes
Lathrop GPM adds portfolio management specialist
Fed Circ decides fate of Orange Book patent covering blockbuster J&J schizophrenia drug
Failure to make findings of fact adds twist to battle over Eliquis in Ireland
Novo Nordisk, Bayer, GSK among giants accused in drug delivery suits